Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide (AC2993) in Type 2 Diabetes on Metformin (AMIGO 1)
NCT00039013Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2002
- Primary completion
- Jun 2003
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Mar 2002; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00039013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039013.